The Patent Finder

Terms ending in 2039

Epicentrx, Inc.

Every in-force patent on Epicentrx, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,357,608METHODS AND COMPOSITIONS UTILIZING RRx-001 COMBINATION THERAPY FOR RADIOPROTECTION
In force
 · High confidence
Epicentrx, Inc.In forceHigh confidence
US 12,280,123Recombinant Adenoviruses Carrying Transgenes
In force
 · High confidence
Epicentrx, Inc.In forceHigh confidence
US 12,036,247Multiple Transgene Recombinant Adenovirus
In force
 · High confidence
Epicentrx, Inc.In forceHigh confidence
US 11,510,901METHODS AND COMPOSITIONS UTILIZING RRx-001 COMBINATION THERAPY FOR RADIOPROTECTION
In force
 · High confidence
Epicentrx, Inc.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited